The global third-party health check-up center market size was valued at USD 34.2 billion in 2025 and is projected to expand at a CAGR of 7.3% during the forecast period (2025-2033), reaching USD 62.3 billion by 2033. The market growth is primarily driven by the increasing prevalence of chronic diseases, rising healthcare costs, and growing awareness about preventive healthcare. The availability of advanced diagnostic tools and technologies has further fueled the demand for third-party health check-up services. The market is segmented by application (male and female) and type (specialized check-up and general check-up). The specialized check-up segment accounted for a larger market share in 2025 due to the growing prevalence of chronic diseases and the need for specialized diagnosis and treatment plans. The general check-up segment is expected to witness a significant growth rate during the forecast period as preventive healthcare measures gain traction. Regionally, North America held the largest market share in 2025, followed by Europe and Asia Pacific. The presence of well-established healthcare systems and high healthcare expenditure in North America has contributed to the region's dominance in the market. The Asia Pacific region is expected to grow at a faster rate during the forecast period due to the increasing healthcare spending and the rising awareness about preventive healthcare in emerging economies. This report provides comprehensive insights into the global third-party health check-up center market, with a particular focus on market concentration, trends, key segments, competitive landscape, and growth drivers. The market is valued at USD 300 million and is projected to reach USD 1.2 billion by 2028, exhibiting a CAGR of 15.2%.

"Health Index. Ukraine" is a large-scale, empirical, and representative study aimed at collecting quantitative data on the population's health-related knowledge and behaviors, as well as their evaluations of healthcare service quality based on personal experiences, and tracking changes in these indicators over time. Launched in 2016, the study has been conducted annually until 2020, with five waves completed during the 2016-2020 period, and resumed in 2023, offering the opportunity to reassess key health-related issues and access to medical services amid the challenges posed by the full-scale war. The study was initiated by the International Renaissance Foundation, with the Charitable Foundation "Health Solutions for Open Society" continuing its legacy as the successor to the Public Health program. The Kyiv International Institute of Sociology (KIIS) has served as the executing agency for the study across all years. Key partners and donors of the project also include the World Bank (2017), the Ministry of Health of Ukraine (2018, 2019, 2020, 2023), and the World Health Organization (2023). The data for this study come from sociological surveys of the adult population, with approximately 10,000 respondents participating in each wave. The sample for each wave is random and representative of the adult population (18 years and older) of Ukraine as a whole, as well as of each oblast covered by the study, including the city of Kyiv. The topics covered by the study include health and health-seeking behaviour, early disease detection, patient experiences with outpatient and inpatient care (including questions on official and unofficial expenses), general perceptions of vaccination and specific behaviours related to child immunization, medication availability, satisfaction with medical care, and perceptions of healthcare reforms. The data collection includes datasets, field questionnaires, and technical reports describing the methodology for all six survey waves. Each dataset is provided as a separate file in SAV format and labeled in Ukrainian. Additionally, the collection includes converted datasets in CSV format, accompanied by codebooks. The study results, including comprehensive analytical reports and selected infographics, are available on the project website: https://healthindex.com.ua/

In 2019, it was estimated that up to 935 billion U.S. dollars in U.S. health care spending was wasteful. That is roughly a quarter of the total U.S. health expenditure that year. The Institute of Medicine identified six waste domains: failure of care delivery, failure of care coordination, overtreatment or low-value care, pricing failure fraud and abuse, and administrative complexity. The highest cost of waste came from administrative complexity, at over a quarter trillion U.S. dollars annually, due to the fragmented U.S. health care system. Other comparable countries spend much less on health administration than the U.S. This statistic shows the estimated U.S. health care spending that can be characterized as waste as of 2019, by waste domain.

The website shows data on the plan and implementation of the health services program by individual health activities (VZD) :

• hospital medical activity,
• general outpatient medical activity,
• specialist outpatient medical activity,
• dental practice,
• other health activities,
• activity of accommodation facilities for patient care,
• social care without accommodation for the elderly and disabled,
• production of pharmaceutical preparations,
• retail trade in specialized stores with pharmaceutical products,
• compulsory social security activity.

Within the framework of each activity, the data for each period are shown separately by contractors and together, the activity by regional units of ZZZS and the activity data at the level of Slovenia together.

Data on the plan and implementation of the health services program are shown in the accounting unit (e.g. points, quotients, weights, groups of comparable cases, non-medical care day, care, days...), which are used to calculate the work performed in the field of individual activities.

The publication of information about the plan and implementation of the program on the ZZZS website is primarily intended for the professional public. The displayed program plan for an individual contractor refers to the defined billing period. (example: The plan for the period 1-3 201X is calculated as 3/12 of the annual plan agreed in the contract).

The data on the implementation of the program represents the implementation of the program at an individual provider for insured persons who benefited from medical services from him during the accounting period. Data on the realization of the program do not refer to persons insured in accordance with the European legal order and bilateral agreements on social security. Data for individual contractors are classified by regional units based on the contractor's headquarters. The content of the data on the "number of cases" is defined in the Instruction on recording and accounting for medical services and issued materials.

The institute reserves the right to change the data, in the event of subsequently discovered irregularities after already published on the Internet.

Personal healthcare spending in the United States. Data are from Health, United States. Source: Centers for Medicare & Medicaid Services, Office of the Actuary, National Health Statistics Group, National Health Expenditure Accounts, National health expenditures.
Search, visualize, and download these and other estimates from over 120 health topics with the NCHS Data Query System (DQS), available from: https://www.cdc.gov/nchs/dataquery/index.htm.

The global academic medical center market is projected to expand at a CAGR of 11.38% over the forecast period (2023-2030), reaching a market value of $819.63 billion by 2030. This growth is driven by several factors, including the rising demand for personalized medicine, the increasing prevalence of chronic diseases, and the growing need for specialized healthcare services. The Asia-Pacific region is expected to witness the highest growth, with the market expanding at a CAGR of 13.78% during the forecast period. This growth is attributed to factors such as the increasing healthcare spending, the growing population, and the expanding healthcare infrastructure in the region. The key segments of the academic medical center market include academic level (undergraduate, graduate, postgraduate), hospital type (university teaching hospitals, community hospitals, private hospitals, public hospitals), focus area (clinical care, research, education), and funding source (government funding, university funding, private donations, patient revenue). The major players operating in the market include Mayo Clinic, University of Toronto, Faculty of Medicine, Johns Hopkins Hospital, Charité – Universitätsmedizin Berlin, University of California, San Francisco Medical Center, NYU Langone Health, University of Washington Medical Center, Cleveland Clinic, University of Oxford, Karolinska Institute, Stanford University Medical Center, University of Edinburgh, UCLA Medical Center, and Massachusetts General Hospital. These players have adopted strategies such as mergers and acquisitions, geographical expansion, and the development of new products and services to enhance their market presence. Recent developments include: , The Academic Medical Center (AMC) market is projected to expand significantly over the coming years, driven by factors such as rising demand for healthcare services, technological advancements, and increasing government initiatives to improve healthcare infrastructure., In 2023, the United States accounted for the largest share of the AMC market. The region's advanced healthcare system, strong research and development capabilities, and high healthcare expenditure are major factors contributing to its dominance., Other key markets include Europe and Asia-Pacific, which are also experiencing significant growth due to increasing demand for healthcare services and government initiatives to improve healthcare infrastructure., Recent news developments in the AMC market include the increasing adoption of telemedicine and digital health technologies, which enable remote patient monitoring and provide greater access to healthcare services., Additionally, there is a growing focus on precision medicine and personalized treatments, which are expected to drive demand for specialized medical centers and advanced diagnostic and treatment technologies., Academic Medical Center Market Segmentation Insights. Key drivers for this market are: Advanced research capabilities Personalized patient care Innovative treatment approaches Precision medicine Data-driven healthcare management . Potential restraints include: 1 Growing demand for specialized healthcare services 2 Technological advancements in medical diagnosis and treatment 3 Increasing collaborations between academia and industry 4 Government initiatives to support medical research and education 5 Rising healthcare costs and insurance coverage limitations .

The global Big Data spending in healthcare is experiencing robust growth, driven by the increasing volume of patient data generated through electronic health records (EHRs), wearables, and medical imaging. This surge in data necessitates sophisticated analytical tools to improve patient care, optimize operational efficiency, and accelerate medical research. The market, currently estimated at $30 billion in 2025, is projected to grow at a Compound Annual Growth Rate (CAGR) of 15% over the forecast period (2025-2033), reaching approximately $100 billion by 2033. Key drivers include the rising adoption of cloud-based solutions for data storage and analysis, the growing demand for predictive analytics in disease management and personalized medicine, and increasing regulatory mandates for data security and interoperability. Hospitals and clinics are the largest consumers of Big Data solutions, followed by research organizations and finance/insurance agencies. The software segment holds the largest market share, fueled by advancements in artificial intelligence (AI) and machine learning (ML) algorithms for data processing and insights generation. However, challenges remain, including data privacy concerns, high implementation costs, and the need for skilled professionals to manage and interpret complex datasets. These restraints could temper growth if not adequately addressed through robust security protocols, cost-effective solutions, and targeted training initiatives. The geographic distribution of Big Data spending in healthcare reflects established healthcare infrastructure and technological advancement. North America, specifically the United States, holds a significant market share due to its advanced healthcare systems and early adoption of Big Data technologies. Europe and Asia Pacific are also experiencing substantial growth, driven by increasing investments in healthcare infrastructure and growing digital health initiatives. However, regional variations exist due to disparities in healthcare spending, regulatory landscapes, and technological maturity. Companies such as IBM, Microsoft, Oracle, SAP, and SAS Institute are key players in this market, offering a comprehensive suite of Big Data solutions, including hardware, software, and IT services. Future market growth will depend on continued technological innovation, improved data interoperability, and the successful addressal of ethical and privacy concerns associated with handling sensitive patient data.

The Ambulatory Surgery Center (ASC) Revenue Cycle Management (RCM) market is experiencing robust growth, driven by the increasing volume of surgical procedures performed in ASCs, the rising adoption of electronic health records (EHRs) and revenue cycle management software, and a growing focus on improving operational efficiency and financial performance within ASCs. The market's expansion is fueled by a shift towards outpatient procedures, reducing healthcare costs and improving patient satisfaction. This trend is further amplified by technological advancements in RCM solutions, including automation, artificial intelligence (AI), and machine learning (ML), which streamline processes like billing, coding, and claims management. Key players like NextGen Healthcare, R1 RCM, and McKesson are actively innovating and expanding their offerings to cater to this growing demand, fostering a competitive landscape characterized by mergers, acquisitions, and strategic partnerships. The market's segmentation is likely influenced by factors like service offerings (e.g., billing, coding, claims processing), software solutions (cloud-based vs. on-premise), and ASC size (large vs. small). Despite the positive growth trajectory, challenges remain. These include the increasing complexity of healthcare regulations and reimbursement policies, the need for skilled personnel to manage sophisticated RCM systems, and the integration challenges faced by ASCs adopting new technologies. However, the potential for significant cost savings and improved financial outcomes through efficient RCM solutions is likely to outweigh these obstacles. We project sustained growth in the ASC RCM market, driven by continued technological innovation, expanding adoption among ASCs, and the ongoing preference for cost-effective outpatient surgeries. The market's size is expected to continue its upward trend, spurred by the increasing need for comprehensive and streamlined revenue cycle management solutions.

The global urgent care center market, valued at $26.80 billion in 2025, is projected to experience robust growth, driven by several key factors. The rising prevalence of chronic diseases requiring frequent, non-emergency care, coupled with increasing healthcare costs and longer wait times at traditional emergency rooms, fuels the demand for convenient and affordable urgent care services. The aging global population further contributes to this trend, as older adults often require more frequent healthcare visits for various ailments. Technological advancements, such as telemedicine integration and advanced diagnostic tools within urgent care centers, are also enhancing efficiency and patient experience, driving market expansion. Furthermore, the increasing adoption of value-based care models by healthcare providers incentivizes the use of cost-effective urgent care options, thus contributing to market growth. Consolidation within the industry and expansion into underserved areas are also important factors driving market expansion. The market is segmented by service type (trauma/injury, vaccination, acute illness treatment, diagnostics, and others) and ownership (corporate, hospital, physician, and others), providing diverse investment and growth opportunities. North America currently dominates the market due to higher healthcare expenditure and well-established urgent care infrastructure. However, emerging economies in Asia-Pacific and other regions are witnessing significant growth potential due to increasing disposable incomes and rising awareness of urgent care benefits. The projected Compound Annual Growth Rate (CAGR) of 4.88% from 2025 to 2033 suggests a significant market expansion over the forecast period. While restraints such as regulatory hurdles and varying reimbursement policies across regions may pose challenges, the overall market outlook remains positive. The increasing demand for accessible and cost-effective healthcare solutions will likely outweigh these challenges, leading to sustained market growth. Strategic partnerships, acquisitions, and technological innovations by major players will continue to shape the competitive landscape and further propel market expansion. The consistent demand for efficient healthcare services positions the urgent care center market for strong, long-term growth. Recent developments include: In March 2022, ICV Partners, LLC, one of the leading investment firm focused on lower middle-market companies in business services, consumer goods & services, food & beverage, and healthcare, acquired the Urgent Care Group (UGC) and its combination with portfolio company Total Access Urgent Care (TAUC)., In January 2022, Boston Children's Hospital and PM Pediatrics started working together to provide premier urgent care for children and young adults in the Boston area. This urgent care collaboration will enable Boston Children's and PM Pediatrics to build on initiative on high-quality clinical care, and enhance the patient experience for pediatric patients in Massachusetts. As part of the collaboration, the two organizations will use their collective pediatric expertise to increase access to healthcare and ensure care for children is delivered in the right setting.. Key drivers for this market are: Growing Geriatric Population, Rising Number of Hospitals Entering Into Urgent Care Market. Potential restraints include: Growing Geriatric Population, Rising Number of Hospitals Entering Into Urgent Care Market. Notable trends are: Hospital Owned Urgent Care Centers Segment is Anticipated to Grow at a High CAGR Over the Forecast Period.

The Healthcare Descriptive Analysis market is experiencing robust growth, projected to reach $18.36 million in 2025 and exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 23.50%. This expansion is fueled by several key drivers. The increasing volume of healthcare data generated from electronic health records (EHRs), medical devices, and wearable sensors necessitates sophisticated analytical tools for efficient management and insightful interpretation. Furthermore, the rising demand for improved patient outcomes, operational efficiency within healthcare organizations, and the ability to conduct proactive, data-driven research are significantly contributing to market growth. The adoption of cloud-based solutions is accelerating, offering scalability and cost-effectiveness compared to on-premise deployments. Clinics and hospitals are leading the adoption, followed by other private organizations. The market is segmented across various applications (clinical, financial, administrative, and research data analytics) and components (software, hardware, and services). Software solutions dominate the market share, leveraging advanced algorithms for data mining, visualization, and predictive modeling. The market's growth trajectory is expected to continue throughout the forecast period (2025-2033). While specific regional market shares are not provided, North America is anticipated to maintain a substantial market share due to early adoption of advanced analytics and robust healthcare infrastructure. The Asia Pacific region, however, is poised for significant growth driven by increasing healthcare expenditure and technological advancements. Competitive pressures are intense, with established players like SAS Institute, Oracle, and IBM competing with specialized healthcare analytics providers such as MedeAnalytics and Health Catalyst. The market faces challenges such as data privacy concerns, the need for skilled data analysts, and the high cost of implementation and maintenance of advanced analytics solutions. However, ongoing technological advancements and increasing government initiatives to improve healthcare data management are expected to mitigate these challenges and drive further market expansion. This comprehensive report provides a detailed analysis of the Healthcare Descriptive Analysis Market, offering invaluable insights for stakeholders across the healthcare IT landscape. With a study period spanning 2019-2033, a base year of 2025, and a forecast period of 2025-2033, this report utilizes extensive data analysis to illuminate market trends, growth drivers, and potential challenges. The market is projected to reach significant values in the millions. Recent developments include: In November 2022, Ursa Health updated Ursa Studio, its healthcare analytics development platform, to help organizations meet the requirements of the Centers for Medicare and Medicaid Services (CMS)., In November 2022, Hartford HealthCare entered a long-term partnership with Google Cloud to advance the healthcare digital transformation, improve data analytics, and enhance care delivery and access.. Key drivers for this market are: Need for Comprehensive Analytics, Integration of Big Data into Healthcare. Potential restraints include: Data Privacy and Security Concerns. Notable trends are: Cloud-based Segment Expected to Hold a Significant Share of the Market During the Forecast Period.

The global Healthcare Financial Analytics market is anticipated to witness robust growth over the forecast period, 2023-2029. The market was valued at US$ 674.52 million in 2022 and is projected to reach US$ 1,276.87 million by 2029, exhibiting a CAGR of 8.58% during the forecast period. Rapid advances in healthcare technology, growing healthcare expenditure, and increasing demand for cost-effective healthcare delivery are the key factors driving the growth of the Healthcare Financial Analytics market. The increasing adoption of cloud-based and on-premises healthcare financial analytics solutions, growing awareness of the benefits of advanced analytics in healthcare, and government initiatives to improve healthcare quality and efficiency are expected to contribute to the growth of the Healthcare Financial Analytics market. Additionally, the rise of value-based healthcare models and the need for accurate and timely financial data to support decision-making in healthcare organizations are creating opportunities for the growth of the Healthcare Financial Analytics market. Market Overview The healthcare financial analytics market is projected to reach USD 33,516.9 Million by 2026, exhibiting a CAGR of 11.2% during the forecast period. The growing demand for cost-effective healthcare delivery, coupled with the need for improved financial management in healthcare organizations, is driving the market growth. Recent developments include: , Recent developments in the Healthcare Financial Analytics Market indicate significant growth and transformation driven by innovations and evolving needs in the sector. Companies like Roche, QuintilesIMS, and Oracle are focusing on enhancing their analytics capabilities to improve healthcare financial management. Allscripts Healthcare Solutions and SAS Institute have recently introduced advanced analytics platforms aimed at streamlining operations and facilitating better decision-making. Market players such as McKesson and Epic Systems are bolstering their offerings through partnerships and technology integration to address the surge in demand for comprehensive financial insights in healthcare institutions., In the mergers and acquisitions landscape, NantHealth's acquisition of key analytics technologies has strengthened its market position, while IBM Watson Health has been expanding its portfolio through strategic alliances, enhancing healthcare outcomes. Furthermore, the growth valuation of companies like Verisk Analytics and Cerner is reflecting positively on the overall market as organizations seek robust financial analytics solutions to navigate the complexities within healthcare finance. These developments underscore the critical importance of advanced analytics in optimizing financial performance while improving patient care outcomes, positioning the sector for sustained growth and innovation., Healthcare Financial Analytics Market Segmentation Insights. Key drivers for this market are: Rising demand for cost containment, Increased adoption of cloud-based solutions; Integration of AI and machine learning; Growing focus on regulatory compliance; Expansion of value-based care models. Potential restraints include: Rising healthcare costs, Increasing regulatory compliance; Demand for data-driven decisions; Growth in telehealth services; Advancements in analytics technologies.

Snapshot img

Healthcare Analytics Market Size 2025-2029

The healthcare analytics market size is forecast to increase by USD 81.28 billion, at a CAGR of 25% between 2024 and 2029.

The market is experiencing significant growth due to several key trends. The integration of big data with healthcare analytics is a major growth factor, enabling healthcare providers to make data-driven decisions and improve patient outcomes.
Another trend is the increasing use of Internet-enabled mobile devices in healthcare services, allowing for remote monitoring and real-time data access. However, data security and privacy concerns remain a challenge, with the need for strong security measures to protect sensitive patient information. These trends are shaping the future of patient engagement and driving growth in the global healthcare analytics market as well.

What will be the Size of the Healthcare Analytics Market During the Forecast Period?

Request Free Sample

The market is experiencing significant growth due to the increasing adoption of digital solutions for improving patient care and reducing treatment costs. Healthcare organizations are leveraging descriptive analytics to gain insights from clinical data, while predictive and prescriptive analytics enable the development of personalized treatment plans and optimal therapeutic strategies. Financial analytics help manage healthcare expenses, ensuring cost-effective patient care. The National Institutes of Health (NIH) and other research institutions are driving innovation in health data analytics, leading to advancements in areas such as patient compliance, medication selection, and disease management. Industry leaders are utilizing artificial intelligence and machine learning to enhance clinical care, outreach, and disease management, ultimately leading to better treatment consistency and optimal outcomes for patients.

How is this Healthcare Analytics Industry segmented and which is the largest segment?

The healthcare analytics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Component

  Services
  Software
  Hardware


Deployment

  On-premise
  Cloud-based


Type

  Descriptive Analysis
  Predictive Analysis
  Prescriptive and Diagnostics


Application

  Financial Analytics
  Clinical Analytics
  Operations and Administrative Analytics
  Population Health Analytics


End-User

  Insurance Company
  Government Agencies
  Healthcare Providers
  Pharmaceutical and Medical Device Companies


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  South America



  Middle East and Africa

By Component Insights

The services segment is estimated to witness significant growth during the forecast period. Healthcare analytics services encompass consulting, learning and training, development and integration, hardware maintenance and support, IT management, process management, and software support. The consulting and software support segments are experiencing significant growth due to the increasing demand for advanced healthcare delivery systems and cost-effective models. The healthcare sector's ongoing transition from on-premises to cloud-based software and IT infrastructure deployment is another growth driver. This shift is expected to increase the demand for IT education and training services. End-users of these services range from individual doctor offices to full-service hospitals and multi-location clinics, including large hospitals and tissue and blood processing organizations.

Get a glance at the share of various segments. Request Free Sample

The services segment was valued at USD 6.7 billion in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

APAC is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American market is driven by the increasing demand for secure data access and effective patient information management. The US and Canada are the primary contributors to this market due to their early adoption of advanced technologies, such as machine learning, predictive analytics, and quantum computing, across various industries. These technologies enable the healthcare sector to optimize patient compliance, medication selection, and therapeutic strategies and, ultimately, achieve optimal outcomes. Major companies in this market provide solutions to help healthcare organizations manage and

The global medical payment integrity and fraud detection market is experiencing robust growth, driven by escalating healthcare costs, increasing instances of fraudulent activities, and the rising adoption of advanced analytics and AI-powered solutions. The market's expansion is fueled by government initiatives aimed at curbing healthcare fraud and waste, coupled with the increasing pressure on healthcare providers to improve financial performance and operational efficiency. Hospitals, clinics, and nursing centers are primary adopters of these technologies, with a preference shifting towards external hosting solutions due to scalability, cost-effectiveness, and reduced IT infrastructure burden. While internal deployment remains a significant segment, particularly for larger organizations with substantial IT capabilities, external hosting is anticipated to witness faster growth over the forecast period (2025-2033). Key players like SAS Institute, Context 4 Healthcare, and Change Healthcare are actively innovating and expanding their product portfolios to cater to evolving market needs, driving competition and fostering further market growth. Geographic expansion is also a key driver, with North America currently holding a dominant market share, followed by Europe and Asia Pacific. However, developing regions are expected to witness significant growth propelled by increasing healthcare expenditure and improved technological infrastructure. Market restraints include the high initial investment costs associated with implementing these solutions, data security and privacy concerns, and the complexity of integrating these systems with existing healthcare IT infrastructure. Despite these challenges, the long-term benefits of reducing fraudulent claims, enhancing revenue cycle management, and improving operational efficiency are expected to outweigh the initial hurdles, resulting in consistent market expansion throughout the forecast period. The market is projected to maintain a healthy CAGR, exceeding the average growth rate of similar technology sectors. This growth is further reinforced by the increasing adoption of big data analytics, machine learning, and artificial intelligence in detecting complex fraud schemes, thereby improving the accuracy and efficiency of payment integrity processes. The continuous evolution of fraud techniques necessitates ongoing innovation in detection methodologies, perpetuating market growth and stimulating the development of more sophisticated and advanced solutions.

NCHS has linked data from various surveys with Medicare program enrollment and health care utilization and expenditure data from the Centers for Medicare & Medicaid Services (CMS). Linkage of the NCHS survey participants with the CMS Medicare data provides the opportunity to study changes in health status, health care utilization and costs, and prescription drug use among Medicare enrollees. Medicare is the federal health insurance program for people who are 65 or older, certain younger people with disabilities, and people with End-Stage Renal Disease.

Results after applying nonparametric bootstrapping. Costs as of 20.03.2014 (1€ = 34,000 rials).

Graph and download economic data for Expenditures: Healthcare by Highest Education: Less Than College Graduate: Associate's Degree (CXUHEALTHLB1406M) from 2012 to 2023 about no college, healthcare, associate degree, health, expenditures, education, and USA.

Migraine is a common chronic brain disorder, characterized by recurring and often disabling attacks of severe headache, with additional symptoms such as photophobia, phonophobia and nausea. Migraine affects especially the working age population. The objective of this retrospective observational register-based study was to analyze the use of healthcare services and associated costs in Finnish migraine patients. Study was based on aggregate data from January 1st, 2020, to December 31st, 2021, from the Finnish Institute for Health and Welfare’s national registries. Patients were grouped into nine patient groups according to medication prescriptions and diagnoses. Healthcare resource utilization in specialty, primary, and occupational healthcare was assessed and analyzed separately for all-cause and migraine related healthcare contacts from a one-year period. The total number of patients was 175 711, and most (45%) of the patients belonged to a group that had used only one triptan. Migraine related total healthcare resource utilization was greater for patients that had used two or more triptans compared to those that had used only one. The patients with three or more preventive medications had the highest total migraine related healthcare resource utilization of the studied patient cohorts. Of the total annual healthcare costs 11.5% (50.6 million €) was associated to be migraine related costs. Total per patient per year healthcare costs were highest with patients that had used three or more preventive medications (5 626 €) and lowest in those with only one triptan (2 257 €). Our findings are in line with the recent European Headache Federation consensus statement regarding the unmet need in patients who have had inadequate response to two or more triptans. When assessing the patient access and cost-effectiveness of novel treatments for the treatment of migraine within different healthcare systems, a holistic analysis of the current disease burden along with potential gains for patients and healthcare service providers are essential information in guiding decision-making.

France Health Expenditure: 2010p: PS: Health Care Spending data was reported at 12.013 EUR bn in 2016. This records a decrease from the previous number of 12.071 EUR bn for 2015. France Health Expenditure: 2010p: PS: Health Care Spending data is updated yearly, averaging 11.268 EUR bn from Dec 2001 (Median) to 2016, with 16 observations. The data reached an all-time high of 12.215 EUR bn in 2013 and a record low of 8.011 EUR bn in 2001. France Health Expenditure: 2010p: PS: Health Care Spending data remains active status in CEIC and is reported by French National Institute for Statistics and Economic Studies. The data is categorized under Global Database’s France – Table FR.G058: Health Statistics: Expenditure: 2010p.

Authors of Costs and Clinical Quality Among Medicare Beneficiaries - Associations with Health Center Penetration of Low-Income Residents, published in Volume 4, Issue 3 of Medicare and Medicaid Research Review, report analyses to determine if increased access to primary care by the underserved had any effect on Medicare spending and clinical quality. Using data on elderly Medicare beneficiaries across U.S. geographic healthcare markets (hospital referral regions, HRRs), data from federally funded health centers, and income data from the American Community Survey, the authors calculated Medicare spending and clinical quality, and compared those outcomes in HRRs with high versus low health center penetration. HRRs with high penetration by health centers had 9.7 percent lower Medicare spending (926 dollars per person) than HRRs with low health center penetration, and no difference in clinical quality outcomes. High health center penetration among low-income populations may accrue Medicare cost savings without compromising clinical quality.

In 2023, Singapore dominated the ranking of the world's health and health systems, followed by Japan and South Korea. The health index score is calculated by evaluating various indicators that assess the health of the population, and access to the services required to sustain good health, including health outcomes, health systems, sickness and risk factors, and mortality rates. The health and health system index score of the top ten countries with the best healthcare system in the world ranged between 82 and 86.9, measured on a scale of zero to 100.

Global Health Security Index  Numerous health and health system indexes have been developed to assess various attributes and aspects of a nation's healthcare system. One such measure is the Global Health Security (GHS) index. This index evaluates the ability of 195 nations to identify, assess, and mitigate biological hazards in addition to political and socioeconomic concerns, the quality of their healthcare systems, and their compliance with international finance and standards. In 2021, the United States was ranked at the top of the GHS index, but due to multiple reasons, the U.S. government failed to effectively manage the COVID-19 pandemic. The GHS Index evaluates capability and identifies preparation gaps; nevertheless, it cannot predict a nation's resource allocation in case of a public health emergency.

Universal Health Coverage Index  Another health index that is used globally by the members of the United Nations (UN) is the universal health care (UHC) service coverage index. The UHC index monitors the country's progress related to the sustainable developmental goal (SDG) number three. The UHC service coverage index tracks 14 indicators related to reproductive, maternal, newborn, and child health, infectious diseases, non-communicable diseases, service capacity, and access to care. The main target of universal health coverage is to ensure that no one is denied access to essential medical services due to financial hardships. In 2021, the UHC index scores ranged from as low as 21 to a high score of 91 across 194 countries.